Projects per year
Search results
-
Active
PRiZM+: A phase II Platform study for Relapsed and Refractory prImary CNS lymphoma with Zanubrutinib
Boucher, B., Jackson, A., Fox, S. & Craddock, C.
1/04/22 → 30/06/26
Project: Research
-
REFRACT (CR-UK): A Sequential Randomised Phase II Trial in Relapsed Follicular comparing standard Chemotherapy with Novel agents
Jackson, A., Fox, S., Gaskell, C. & McIlroy, G.
Genmab A/S, Cancer Research Uk
1/02/22 → 31/07/32
Project: Research
-
FEDORA: A phase II study to evaluate the safety, toxicity and tolerability of the combination of fedratinib and ropeginterferon alfa-2b, in patients with myelofibrosis
Fox, S., Craddock, C. & Jackson, A.
AOP Orphan Pharmaceuticals GmbH
31/12/21 → 30/06/26
Project: Research
-
FEDORA - A phase II study to evaluate the tolerability, safety and activity of fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis
Jackson, A., Fox, S. & Craddock, C.
3/12/21 → 30/06/26
Project: Industry
-
A randomised phase 2 study of ASTX727 versus best supportive care in MDS/MPN Overlap Syndromes
Fox, S., Boucher, B., Craddock, C. & Jackson, A.
1/03/21 → 31/08/25
Project: Research
-
FaR-RMS - An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma
Bowden, S., Kearns, P., Gatz, S., Pirrie, S., Jackson, A., Liu, W. & Gaunt, P.
1/01/21 → 30/06/31
Project: EU
-
COVID19 BMT: A prospective non interventional study to evaluate the role of immune and inflammatory response in recipients of allogeneic haematopoietic stem cell transplantation (SCT) affected by severe COVID19 infection
Bishop, R., Craddock, C. & Jackson, A.
1/08/20 → 31/12/25
Project: Industry
-
PACE: The impact of COVID-19 on patients with AML undergoing chemotherapy: an epidemiological study
Jackson, A., Craddock, C., Loke, J., Boucher, B. & Fox, S.
CELGENE INTERNATIONAL II SARL, BLOODWISE
1/04/20 → 30/06/25
Project: Research
-
COSI: An international randomised clinical trial of therapeutic interventions with the potential to improve outcome in adults with acute myeloid leukaemia and high risk myelodysplasia undergoing allogeneic stem cell transplantation
Craddock, C. & Jackson, A.
Jazz Pharmaceuticals, ADIENNE s.r.l
1/09/19 → 31/12/26
Project: Industry
-
STELLAR: A Phase 2, Randomised Study of CHOP-R in Combination with acalabrutinib followed by acalabrutinib maintenance compared to CHOP-R followed by acalabrutinib at disease progression for patients...
Craddock, C., Jackson, A., Boucher, B., Siddique, S. & Wheatley, K.
7/12/18 → 6/06/26
Project: Research
-
HR-MB: An international High-Risk Medulloblastoma trial
Lawson, A., Kearns, P., Gates, S., Gaunt, P., Pirrie, S., Billingham, L., Homer, V., Jackson, A. & Slade, D.
Cancer Research Uk, SIOP Europe
1/10/18 → 30/09/29
Project: Research
-
AMADEUS - Double-blind,IMPACT phase III,Randomised Study to Compare the Efficacy and Safety to Oral AZA(CC-486)Versus Placebo in Subject with Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance after Allogeneic Haematopoietic
Craddock, C., Siddique, S. & Jackson, A.
1/04/18 → 31/03/28
Project: Industry
-
CRUK/17/011 FaR-RMS: A multiarm-multistage study for children and adults with localised and metastatic frontline and relapsed RhabdoMyoSarcoma.
Kearns, P., Gatz, S., Liu, W., Gaunt, P., Jackson, A. & Pirrie, S.
Cancer Research Uk, SIOP Europe
1/02/18 → 31/01/28
Project: Research
-
A Phase 2a trial of Avelumab, an anti-PDL 1 antibody, in relapsed and refractory peripheral T-cell lymphoma (AVAIL-T)
Siddique, S., Jackson, A. & Craddock, C.
6/07/17 → 31/12/24
Project: Industry
-
PHAZAR/RuxAza - A phase Ib study to assess the safety and tolerability of oral Ruxolitinib in combination with 5 azacitidine in patients with accelerated phase MPNs, MDS or AML after MPNs
Siddique, S., Fox, S., Fenwick, N. & Jackson, A.
BLOODWISE, CELGENE INTERNATIONAL SARL, NOVARTIS PHARMACEUTICALS UK LTD
1/04/14 → 31/12/24
Project: Research
-
Finished
Risk-stratified sequential treatment of de-novo post-transplant lymphoproliferative disorder (PTLD) with Ibrutinib and Rituximab (IR) and IR-CHOP
Craddock, C. & Jackson, A.
BLOODWISE, Janssen-Cilag Limited
1/12/15 → 31/12/23
Project: Research
-
Effects of Tamoxifen on the Mutant Allele Burden and Disease Course in Patients with Myeloproliferative Neoplasms
Craddock, C., Siddique, S. & Jackson, A.
1/12/15 → 31/12/21
Project: Research
-
TIER - APhase I/II Study of Thiotepa, Ifosphamide, Etoposide & Rituximab for the treatment of relapsed & refractory primary central nervous system lymphoma
Siddique, S. & Jackson, A.
15/01/14 → 1/06/21
Project: Research